SUN-122 Nuclear PDCD4 Expression Predicts Good Clinical Outcome in Luminal A-Like and Luminal B-Like Breast Cancer Subtypes

Hormone receptor-positive (HR+, estrogen and/or progesterone receptor-positive) and HER2-negative breast cancer (BC) subtype is a biologically heterogeneous entity that comprises 70% of BCs. This subtype includes both luminal (Lum) A- and B-like subtypes, which have differences in prognosis and sens...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Endocr Soc
Autori principali: Madera, Santiago, Chiauzzi, Violeta A, Chervo, María F, Pereyra, Matías G, Venturutti, Leandro, Deamicis, Agustina Roldán, Dupont, Agustina, Guzmán, Pablo, Roa, Juan C, Cenciarini, Mauro E, Barchuk, Sabrina, Figurelli, Silvina, Vecchia, Daniel Lopez Della, Ares, Sandra, Proietti, Cecilia J, Deza, Ernesto Gil, Gercovich, Felipe G, Schillaci, Roxana, Elizalde, Patricia V, Cordo Russo, Rosalia I
Natura: Artigo
Lingua:Inglês
Pubblicazione: Oxford University Press 2020
Soggetti:
Tumor Biology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208765/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvaa046.1037
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi